MyFinsight
Home
Blog
About
Back
Income Statement
Imunon, Inc. (IMNN)
Imunon, Inc. (IMNN)
source: myfinsight.com
Net loss available
to common share...
-$2,832,166
Net loss
-$2,814,114
(-2.68%↓ Y/Y)
Deemed dividend series
a preferred stock
$18,052
Loss from operations
-$2,791,546
(-0.86%↓ Y/Y)
Total other income
(expense), net
-$22,568
(-182.65%↓ Y/Y)
Investment income, net
$32,518
(19.09%↑ Y/Y)
Change in fair value of
derivative liability
$22,187
Total operating
expenses
$2,791,546
(0.86%↑ Y/Y)
Interest expense
$77,273
Research and development
$1,464,655
(19.37%↑ Y/Y)
General and
administrative
$1,326,891
(-13.89%↓ Y/Y)
Back